DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 168 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,000 | +66.7% | 600 | +35.7% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 442 | -9.1% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 486 | -14.3% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 567 | -18.1% | 0.00% | – |
| Q4 2018 | $7,000 | -87.0% | 692 | -72.3% | 0.00% | -100.0% |
| Q3 2017 | $54,000 | +671.4% | 2,500 | +257.1% | 0.01% | +400.0% |
| Q2 2017 | $7,000 | -97.3% | 700 | -93.5% | 0.00% | -97.5% |
| Q4 2015 | $261,000 | -18.2% | 10,805 | -16.9% | 0.04% | -13.0% |
| Q3 2015 | $319,000 | – | 13,005 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |